Covisint Corp (COVS) [Rocket]

Overview

Covisint Corp (COVS)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
02/13/2018	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/10/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/07/2017	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]:
08/07/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/07/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/28/2017	4	Digirolamo Enrico (CFO) has filed a Form 4 on Covisint Corp
07/28/2017	4	Form 4 - Statement of changes in beneficial ownership of securities:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Mar-31-17	Mar-31-16	Mar-31-15	Mar-31-14	Mar-31-13	Mar-31-12
Revenues	70.2	76.0	88.5	97.1	91.9	69.7
Revenue growth	-7.6%	-14.1%	-8.9%	5.7%	31.9%
Cost of goods sold	33.3	35.0	66.4	56.4	0.0	0.0
Gross profit	37.0	41.1	22.1	40.8	91.9	69.7
Gross margin	52.6%	54.0%	25.0%	42.0%	100.0%	100.0%
Sales and marketing	26.8	29.4	32.6	35.3	26.6	22.5
Research and development	11.4	13.0	10.4	12.4
General and administrative	11.5	13.3	17.6	28.7
EBITA	-8.4	-11.3	-31.3	-28.5	48.6	36.7
EBITA margin	-12.0%	-14.8%	-35.4%	-29.3%	52.9%	52.7%
Amortization of intangibles	4.3	3.4	7.2	7.1	5.4	3.5
EBIT	-12.7	-14.7	-38.5	-35.6	43.2	33.2
EBIT margin	-18.1%	-19.3%	-43.5%	-36.6%	47.0%	47.7%
Pre-tax income	-12.7	-14.7	-38.5	-35.6	-5.6	-3.3
Income taxes	0.1	0.2	0.1	0.1	0.1	0.1
Net income	-12.7	-14.9	-38.6	-35.7	-5.7	-3.3
Net margin	-18.1%	-19.6%	-43.6%	-36.7%	-6.2%	-4.8%

Diluted EPS	($0.31)	($0.38)	($1.01)	($1.06)	($0.19)	($0.11)
Shares outstanding (diluted)	40.7	39.7	38.2	33.8	30.0	30.0

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.